FDA-approved uses based on clinical trial evidence are referred to as what?

FDA-approved uses based on clinical trial evidence are referred to as what?

• A. Post-Market Surveillance
• B. Labeled Indications
• C. Black Box Warnings
• D. Orphan Drugs

Answer: (B)

Label indications are the uses for which the FDA has approved a drug based on evidence from clinical trials, and these indications appear in the drug’s labeling. This labeling defines what the drug is officially approved to treat, with the appropriate dosing and safety information. Off-label use refers to prescribing outside these approved indications, which is not FDA-approved. Post-market surveillance monitors safety after approval; Black Box Warnings highlight the most serious risks on the labeling; Orphan drugs are therapies developed for rare diseases. So, the FDA-approved uses based on trial evidence are the labeled indications.

Label indications are the uses for which the FDA has approved a drug based on evidence from clinical trials, and these indications appear in the drug’s labeling. This labeling defines what the drug is officially approved to treat, with the appropriate dosing and safety information. Off-label use refers to prescribing outside these approved indications, which is not FDA-approved. Post-market surveillance monitors safety after approval; Black Box Warnings highlight the most serious risks on the labeling; Orphan drugs are therapies developed for rare diseases. So, the FDA-approved uses based on trial evidence are the labeled indications.